BaxDuo Arctic: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure
BaxDuo Pacific: A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure (BaxDuo-Pacific)
EASi-KIDNEY: A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease
SIRIUS-LN - CVAY36K12301: A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in participants with active lupus nephritis (SIRIUS-LN)
eliPfad: Personalisierter, interdisziplinärer Patientenpfad zur sektorenübergreifenden Versorgung multimorbider Patientinnen und Patienten
Klinikdirektor
Prof. Dr. med. Timm H. Westhoff
Katja Fritz
Gesamtleitung Studienzentrum
Fon: 0 23 23 - 499 - 6290
E-Mail: studienkoordination@
elisabethgruppe.de